Thermo Fisher Scientific Gross Margin 2010-2025 | TMO
Thermo Fisher Scientific Gross Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Gross Profit | Gross Margin |
2025-03-31 | $42.90B | $17.73B | 41.34% |
2024-12-31 | $42.88B | $17.70B | 41.28% |
2024-09-30 | $42.37B | $17.27B | 40.77% |
2024-06-30 | $42.35B | $17.26B | 40.76% |
2024-03-31 | $42.49B | $17.17B | 40.40% |
2023-12-31 | $42.86B | $17.10B | 39.90% |
2023-09-30 | $43.42B | $17.31B | 39.87% |
2023-06-30 | $43.52B | $17.30B | 39.75% |
2023-03-31 | $43.81B | $17.65B | 40.28% |
2022-12-31 | $44.92B | $18.97B | 42.24% |
2022-09-30 | $44.17B | $19.62B | 44.42% |
2022-06-30 | $42.82B | $19.97B | 46.63% |
2022-03-31 | $41.12B | $19.89B | 48.37% |
2021-12-31 | $39.21B | $19.64B | 50.08% |
2021-09-30 | $39.06B | $19.94B | 51.05% |
2021-06-30 | $38.25B | $19.62B | 51.29% |
2021-03-31 | $35.89B | $18.47B | 51.47% |
2020-12-31 | $32.22B | $16.00B | 49.67% |
2020-09-30 | $28.50B | $13.48B | 47.31% |
2020-06-30 | $26.25B | $11.92B | 45.39% |
2020-03-31 | $25.65B | $11.36B | 44.30% |
2019-12-31 | $25.54B | $11.33B | 44.35% |
2019-09-30 | $25.22B | $11.22B | 44.48% |
2019-06-30 | $24.87B | $11.07B | 44.51% |
2019-03-31 | $24.63B | $10.98B | 44.60% |
2018-12-31 | $24.36B | $10.86B | 44.57% |
2018-09-30 | $23.90B | $10.60B | 44.37% |
2018-06-30 | $23.09B | $10.29B | 44.55% |
2018-03-31 | $22.01B | $9.84B | 44.69% |
2017-12-31 | $20.92B | $9.45B | 45.17% |
2017-09-30 | $19.82B | $9.06B | 45.70% |
2017-06-30 | $19.20B | $8.81B | 45.90% |
2017-03-31 | $18.74B | $8.61B | 45.92% |
2016-12-31 | $18.27B | $8.37B | 45.82% |
2016-09-30 | $17.97B | $8.20B | 45.62% |
2016-06-30 | $17.61B | $8.03B | 45.60% |
2016-03-31 | $17.34B | $7.89B | 45.50% |
2015-12-31 | $16.97B | $7.76B | 45.72% |
2015-09-30 | $16.81B | $7.74B | 46.05% |
2015-06-30 | $16.85B | $7.79B | 46.23% |
2015-03-31 | $16.91B | $7.70B | 45.52% |
2014-12-31 | $16.89B | $7.49B | 44.36% |
2014-09-30 | $15.86B | $6.88B | 43.39% |
2014-06-30 | $14.89B | $6.30B | 42.30% |
2014-03-31 | $13.80B | $5.81B | 42.11% |
2013-12-31 | $13.09B | $5.53B | 42.24% |
2013-09-30 | $12.88B | $5.43B | 42.17% |
2013-06-30 | $12.78B | $5.38B | 42.13% |
2013-03-31 | $12.65B | $5.34B | 42.24% |
2012-12-31 | $12.51B | $5.30B | 42.33% |
2012-09-30 | $12.30B | $5.20B | 42.29% |
2012-06-30 | $12.15B | $5.12B | 42.18% |
2012-03-31 | $11.90B | $4.96B | 41.73% |
2011-12-31 | $11.56B | $4.79B | 41.47% |
2011-09-30 | $11.05B | $4.59B | 41.49% |
2011-06-30 | $10.75B | $4.43B | 41.21% |
2011-03-31 | $10.49B | $4.32B | 41.15% |
2010-12-31 | $10.39B | $4.26B | 41.00% |
2010-09-30 | $10.49B | $4.19B | 39.91% |
2010-06-30 | $10.40B | $4.14B | 39.80% |
2010-03-31 | $10.28B | $4.08B | 39.64% |
2009-12-31 | $9.91B | $3.90B | 39.32% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $156.252B | $42.879B |
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Intuitive Surgical (ISRG) | United States | $201.298B | 88.17 |
Edwards Lifesciences (EW) | United States | $45.778B | 30.01 |
Alcon (ALC) | Switzerland | $44.076B | 29.79 |
IDEXX Laboratories (IDXX) | United States | $41.955B | 48.21 |
DexCom (DXCM) | United States | $34.098B | 52.70 |
IQVIA Holdings (IQV) | United States | $24.832B | 13.91 |
STERIS (STE) | Ireland | $24.813B | 27.36 |
Mettler-Toledo (MTD) | United States | $24.089B | 28.65 |
Waters (WAT) | United States | $21.336B | 30.10 |
SONOVA HOLDING (SONVY) | Switzerland | $20.297B | 0.00 |
Hologic (HOLX) | United States | $12.575B | 13.66 |
Penumbra (PEN) | United States | $10.904B | 85.58 |
Sysmex ADR (SSMXY) | Japan | $10.525B | 29.86 |
Masimo (MASI) | United States | $8.411B | 31.03 |
Globus Medical (GMED) | United States | $8.397B | 19.69 |
Teleflex (TFX) | United States | $5.662B | 9.35 |
Glaukos (GKOS) | United States | $5.477B | 0.00 |
Integer Holdings (ITGR) | United States | $4.238B | 22.20 |
TransMedics (TMDX) | United States | $4.130B | 89.78 |
PROCEPT BioRobotics (PRCT) | United States | $3.280B | 0.00 |
LivaNova (LIVN) | United Kingdom | $2.398B | 14.28 |
Veracyte (VCYT) | United States | $2.271B | 31.87 |
Nihon Kohden (NHNKY) | Japan | $2.119B | 24.30 |
Elekta AB (EKTAY) | Sweden | $2.079B | 18.69 |
Alphatec Holdings (ATEC) | United States | $1.905B | 0.00 |
Tandem Diabetes Care (TNDM) | United States | $1.514B | 0.00 |
Artivion (AORT) | United States | $1.269B | 118.84 |
Pulse Biosciences (PLSE) | United States | $1.152B | 0.00 |
OPKO Health (OPK) | United States | $1.055B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $1.053B | 5.60 |
SiBone (SIBN) | United States | $0.829B | 0.00 |
IRadimed (IRMD) | United States | $0.689B | 34.97 |
RxSight (RXST) | United States | $0.663B | 0.00 |
Beta Bionics (BBNX) | United States | $0.655B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.644B | 14.08 |
Delcath Systems (DCTH) | United States | $0.630B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.601B | 9.35 |
NeuroPace (NPCE) | United States | $0.558B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.557B | 0.00 |
AxoGen (AXGN) | United States | $0.536B | 0.00 |
Semler Scientific (SMLR) | United States | $0.483B | 12.84 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.471B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.423B | 0.00 |
AngioDynamics (ANGO) | United States | $0.389B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.367B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.306B | 0.00 |
Neuronetics (STIM) | United States | $0.282B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.242B | 14.65 |
Alpha Tau Medical (DRTS) | Israel | $0.218B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.184B | 0.00 |
CVRx (CVRX) | United States | $0.179B | 0.00 |
908 Devices (MASS) | United States | $0.171B | 0.00 |
Sight Sciences (SGHT) | United States | $0.169B | 0.00 |
Accuray (ARAY) | United States | $0.167B | 0.00 |
LENSAR (LNSR) | United States | $0.166B | 0.00 |
Inogen (INGN) | United States | $0.165B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.145B | 0.00 |
Anteris Technologies Global (AVR) | Australia | $0.144B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.137B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.136B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.127B | 0.00 |
Microbot Medical (MBOT) | United States | $0.100B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.096B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.078B | 47.30 |
EDAP TMS S.A (EDAP) | France | $0.070B | 0.00 |
InspireMD (NSPR) | Israel | $0.069B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.069B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.064B | 0.00 |
Covalon Technologies (CVALF) | Canada | $0.051B | 15.50 |
Hyperfine (HYPR) | United States | $0.049B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
Envoy Medical (COCH) | United States | $0.036B | 0.00 |
Precision Optics (POCI) | United States | $0.034B | 0.00 |
Spectral AI (MDAI) | United States | $0.034B | 0.00 |
Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
DarioHealth (DRIO) | United States | $0.029B | 0.00 |
Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
NexGel (NXGL) | United States | $0.018B | 0.00 |
PAVmed (PAVM) | United States | $0.011B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
Tenon Medical (TNON) | United States | $0.009B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
Nuwellis (NUWE) | United States | $0.004B | 0.00 |
Venus Concept (VERO) | Canada | $0.003B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
Avinger (AVGR) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.66 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |